Hisham Mohamed Abdel-Azim MD
Assistant Professor, Pediatrics, USC School of Medicine
Join to View Full Profile
4650 W Sunset BlvdMs# 62Los Angeles, CA 90027
Phone+1 323-669-4559
Fax+1 323-660-1904
Are you Dr. Abdel-Azim?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Hisham Abdel-Azim, MD is a pediatric hematologist/oncologist in Los Angeles, California. He is currently licensed to practice medicine in California and Maine. He is an Assistant Professor at USC School of Medicine.
Education & Training
Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 2002 - 2005
Westchester Medical CenterResidency, Pediatrics, 2000 - 2002
Cairo University School of MedicineClass of 1993
Ain Shams University Faculty of Medicine
Certifications & Licensure
CA State Medical License 2002 - 2026
ME State Medical License Active through 2020
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Exploring treatment-driven subclonal evolution of prognostic triple biomarkers: Dual gene fusions and chimeric RNA variants in novel subtypes of acute myeloid leukemia...Yi Xu, Shengwen Calvin Li, Jeffrey Xiao, Qian Liu, Durga Cherukuri
Drug Resistance Updates. 2025-03-01 - 1 citationsEffect of rabbit ATG PK on outcomes after TCR-αβ/CD19-depleted pediatric haploidentical HCT for hematologic malignancy.Christopher C Dvorak, Janel R Long-Boyle, Lucia Holbrook-Brown, Hisham Abdel-Azim, Alice Bertaina
Blood Advances. 2024-12-10 - Development of a Competitive Nutrient-Based T-Cell Immunotherapy Designed to Block the Adaptive Warburg Effect in Acute Myeloid Leukemia.Huynh Cao, Jeffrey Xiao, David J Baylink, Vinh Nguyen, Nathan Shim
Biomedicines. 2024-10-03
Press Mentions
Loma Linda University Health Is First in Southern California to Pioneer Beta Thalassemia FDA Approved Gene Therapy; Allows Patient to Skip Monthly Transfusion for the First Time in 35 YearsMarch 27th, 2025
LLUH First in Southern California to Offer Beta Thalassemia Gene TherapyMarch 27th, 2025- Study: Emerging Method of Stem Cell Transplantation Improves Outcomes in Children with Blood CancersJuly 14th, 2022
- Join now to see all
